Appeals Court Ruling Upholds Some Limits on Abortion Pill But Leaves Access Unchanged for Now

Restrictions imposed by appeals court include banning mail order prescriptions and limiting use to first 7 weeks.
Supreme Court previously ruled access must stay the same during legal proceedings, so restrictions not in effect yet.
Case challenges FDA's approval process for mifepristone and seeks to overturn regulatory changes since 2000.
Ruling praised by anti-abortion groups but criticized by rights advocates as restricting reproductive healthcare access.
Next steps are Justice Department appeal to Supreme Court, which may decide access rules for medication abortion.